Grufity logoGrufity logo
Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
RVPH

RVPH - Reviva Pharmaceuticals Holdings Stock Price, Fair Value and News

$1.22-0.22 (-15.28%)
Delayed as of 23 Oct 2024, 02:55 pm ET
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

RVPH Price Action

Last 7 days

17.1%

Last 30 days

12.5%

Last 90 days

22.0%

Trailing 12 Months

-62.3%

RVPH RSI Chart

AprJulOct020406080100

RVPH Valuation

Market Cap

42.9M

Price/Earnings (Trailing)

-1.19

EV/EBITDA

-1.03

Price/Free Cashflow

-1.22

MarketCap/EBT

-1.2

RVPH Price/Earnings (Trailing)

202220232024-20-15-10-50

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

RVPH Fundamentals

RVPH Earnings

Earnings (TTM)

-36.0M

Earnings Growth (Yr)

32.87%

Earnings Growth (Qtr)

-5.73%

20202021202220232024-40M-30M-20M-10M0

RVPH Profitability

Return on Equity

595.79%

Return on Assets

-446.99%

Free Cashflow Yield

-82.12%

RVPH Investor Care

Shares Dilution (1Y)

31.64%

About Reviva Pharmaceuticals Holdings

RVPH
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino, California.
 CEO
 WEBSITEhttps://revivapharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES10

Reviva Pharmaceuticals Holdings Frequently Asked Questions

What is the ticker symbol for Reviva Pharmaceuticals Holdings? What does RVPH stand for in stocks?

RVPH is the stock ticker symbol of Reviva Pharmaceuticals Holdings. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Reviva Pharmaceuticals Holdings (RVPH)?

As of Tue Oct 22 2024, market cap of Reviva Pharmaceuticals Holdings is 42.94 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RVPH stock?

You can check RVPH's fair value in chart for subscribers.

Is Reviva Pharmaceuticals Holdings a good stock to buy?

The fair value guage provides a quick view whether RVPH is over valued or under valued. Whether Reviva Pharmaceuticals Holdings is cheap or expensive depends on the assumptions which impact Reviva Pharmaceuticals Holdings's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RVPH.